Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (11)

2012

  1. The undiagnosed cases of Clostridium difficile infection in a whole nation: Where is the problem?

    Clinical Microbiology and Infection, Vol. 18, Núm. 7

2010

  1. Antimicrobial resistance among respiratory pathogens in Spain: Latest data and changes over 11 years (1996-1997 to 2006-2007)

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 7, pp. 2953-2959

2007

  1. Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: Age-related differences

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 206-210

2006

  1. Invasive pneumococcal disease among children in a health district of Barcelona: Early impact of pneumococcal conjugate vaccine

    Clinical Microbiology and Infection, Vol. 12, Núm. 9, pp. 867-872

2003

  1. Evolution of penicillin and erythromycin co-resistance in Streptococcus pneumoniae in Spain

    International Journal of Antimicrobial Agents, Vol. 22, Núm. 5, pp. 541-544

2002

  1. Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]

    Journal of Antimicrobial Chemotherapy

2000

  1. Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: The impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics

    Journal of Antimicrobial Chemotherapy, Vol. 46, Núm. 4, pp. 557-564

1999

  1. Whole cell lysate enzyme immunoassays vs. Recombinant glycoprotein G2- based immunoassays for HSV-2 seroprevalence studies

    Journal of Medical Virology, Vol. 59, Núm. 4, pp. 502-506

1998

  1. Situación epidemiológica actual y resistencia de los patógenos respiratorios en Espan̄a

    Medicina Clinica, Vol. 110, Núm. SUPPL. 1, pp. 44-51

1997

  1. Non-recombinant vs. Type specific protein HSV-2 assays for seroprevalence studies: Which one to choose?

    Clinical Infectious Diseases, Vol. 25, Núm. 2, pp. 410

1995

  1. Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin

    European Journal of Clinical Microbiology & Infectious Diseases, Vol. 14, Núm. 3, pp. 244-252